I agree with your point about Xena's posts.
In regards to the company being more aggressive about defending against those working to destroy it, I sent this to IR last week:
Sent: Thu, Jul 28, 2016 12:59 pm
Subject: Concerned share holder
Hello,
I am an investor with Anavex holding a large position since November, 2015. I have a simple question:
Is Dr. Missling going to address shareholders to tell us, with some specifics, what is going on in the company? I do think and expect that in light of the market reaction to the information disclosed yesterday at the AAIC, the management team needs to provide, in some detail, information that tell us a bit more than what is typically communicated through the ongoing PR's or power point corporate presentations. Here a some of the topics I/we are interested in learning more about:
- Ph3 for Alzheimer's trial. Timeline for execution, number of participants, locations, funding, etc.
- What is the status of the MJF foundation-funded evaluation for Parkinson's.
- Next steps in regards to the ODD developments for: Rett, Infantile Spasms, Frontotemporal Dementia. What about Epilepsy?
- Status of: Partnerships- I/we understand that this needs to be done carefully and without specifics, but at minimum we need to get an indication that there is activity on this front. Status of the SEC investigation and class actions lawsuits.
- Public rebuttal to some of the false claims being written by biased press with financial interest in seeing the company fail.
I primarily speak for my self but I strongly believe that I represent the sentiments of many investors, exchanging information in social media, who continue to believe in the science and integrity and capability of the management team and are anxious go get a better insight, again within the legal constraints allowed by the law/SEC, into the key activities the company is pursuing. One typically expects this to be done in quarterly earnings calls or as management sees fit based on important developments. The debacle in the stock price after the latest disclosure is one such event that in my opinion requires the CEO to be proactive in reassuring his investors about the future of the company.
Thank you for your attention and hopefully quick response. Best regards,
My name and contact info.
-------
I encourage us longs to continue to demand that the company operates more like most public companies do when it comes to informing shareholders. The upcoming quarterly update (Aug 11?) is a perfect opportunity for Dr. Missling to either hold a conference call or at minimum provide a letter to shareholders. Since we expect news to remain positive, this in my opinion can start to generate more interest institutional investors and financial analysts to invest and cover Anavex.
AI
